SPDR S&P Biotech ETF (NYSEARCA:XBI) Position Boosted by Whittier Trust Co.

Whittier Trust Co. raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 320,740 shares of the exchange traded fund’s stock after acquiring an additional 9,713 shares during the period. Whittier Trust Co.’s holdings in SPDR S&P Biotech ETF were worth $28,885,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Howard Capital Management Group LLC raised its stake in shares of SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after purchasing an additional 6,188 shares in the last quarter. Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $49,000. Biltmore Family Office LLC raised its position in shares of SPDR S&P Biotech ETF by 5.6% during the 3rd quarter. Biltmore Family Office LLC now owns 19,156 shares of the exchange traded fund’s stock worth $1,893,000 after buying an additional 1,009 shares in the last quarter. Nwam LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $1,475,000. Finally, Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $87.46 on Thursday. The stock has a market cap of $5.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The stock’s 50 day moving average price is $89.75 and its 200 day moving average price is $94.53.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.